August 19-20, 2018
Kansas City Convention Center
301 W 13th St. 2100 Entrance, Room 2103 A
Kansas City, MO 64105
Sunday, August 19
1:00 – 5:15 PM
Light Lunch Included
Monday, August 20
7:45 AM – 2:30 PM
Breakfast and Lunch Included
CRISPR/cas9 technology is a simple yet powerful tool for editing genomes. It allows researchers to easily alter DNA sequences and modify gene function. Its many potential applications include correcting genetic defects, treating and preventing the spread of diseases and improving crops.
“CRISPR” stands for “clusters of regularly interspaced short palindromic repeats.” It is a specialized region of DNA with two distinct characteristics: the presence of nucleotide repeats and spacers.
Kevin Davies, PhD, Executive Vice President, Strategic Development, Mary Ann Liebert, Inc.
Richard Payne, MD, John B. Francis Chair in Bioethics, Center for Practical Bioethics
Stanley Qi, PhD, Assistant Professor, Department of Bioengineering, Department of Chemical & Systems Biology, Stanford University
Shondra Miller, PhD, Director, Center for Advanced Genome Engineering, St. Jude Children’s Research Hospital